Medical Devices > Nova Content
Federal Circuit Summary
Before Lourie, O’Malley, and Stoll. Appeal from the United States International Trade Commission.
Summary: After... Read More »
Medical devices are increasingly incorporating software and other computer elements, but software and computer patents are in the middle of a multi-year battle... Read More »
The United States Food and Drug Administration recently announced approval for Teva Pharmaceuticals to market generic epinephrine autoinjectors. According to... Read More »
The medical device and related markets have shown some growth recently. For example, IHI, an iShares U.S. Medical Devices ETF, has a total return of about 24%... Read More »
The Los Angeles-based medical device company BioSig Technologies, Inc. announced in a press release the FDA 510(k) clearance of its PURE EP System, which is designed... Read More »
MaxQ-AI (previously known as MedyMatch) recently filed for an $8 million IPO. According to Nasdaq, MaxQ-AI filed confidentially on February 13. The prosepectus... Read More »
The Food and Drug Administration (FDA) has announced a medical device innovation challenge to help address opioid abuse and misuse. With the FDA Innovation... Read More »
On July 19th, 2018, the United States Department of Veterans Affairs (VA) and IBM Watson Health announced an extension of their ongoing partnership to interpret... Read More »
Envision Healthcare Corporation (“Envision”) recently announced an agreement to be acquired by KKR & Co. L.P. (“KKR”) for about $5.5... Read More »
Stryker recently announced an agreement to acquire SafeAir AG, a Swiss surgical smoke evacuation company. The acquisition will likely close by the end of 2018.
... Read More »
President Donald Trump’s 25 percent tariffs on Chinese imports went into effect on July 6, a move that, according to industry experts, could have wide-ranging... Read More »
Senseonics recently received Premarket Approval from the Food and Drug Administration (FDA) for its Eversense® Continuous Glucose Monitoring (CGM) System... Read More »
Federal Circuit Summary
Before Prost, Moore, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: An IPR petitioner bears the burden of... Read More »
The market for medical device connectivity is projected to reach about $2.6 billion by the year 2023, according to a report published in April 2018 by several... Read More »
On May 30, 2018, the Food and Drug Administration announced the approval of the CustomFlex Artificial Iris. According to the FDA, this is the first approved... Read More »
Federal Circuit Summary
Before PROST, Wallach, and Taranto. Appeal from the Southern District of Indiana.
Summary: In determining whether a... Read More »
Federal Circuit Summary
Before Taranto, Plager, and Chen. Appeal from the Patent Trials and Appeals Board.
Summary: In determining whether materials... Read More »
DePuy Synthes, a part of the Johnson & Johnson Medical Devices Companies, announced recently that it has signed a definitive agreement to acquire the assets of... Read More »
I know that Fed. Cir. s 101 decisions are inherently more instructive than PTAB decisions, but PTAB (and district court) s. 101 decisions are like legal potato chips... Read More »
Federal Circuit Summary
Before Prost, Newman, and Lourie. Appeal from the United States Patent and Trademark Office (PTAB)
Summary: A limitation that merely... Read More »